{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T21:14:55Z","timestamp":1794863695176,"version":"4.9.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"38","license":[{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2026,10,7]]},"DOI":"10.1038\/s41388-026-03935-1","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T04:28:51Z","timestamp":1785817731000},"page":"4077-4087","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["CHAF1A promotes RAD51 loading and homologous recombination to drive tumor radioresistance"],"prefix":"10.1038","volume":"45","author":[{"given":"Ruru","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhicheng","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xipeng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenglan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4691-3257","authenticated-orcid":false,"given":"Guoping","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6362-3569","authenticated-orcid":false,"given":"Feng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,4]]},"reference":[{"key":"3935_CR1","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s41392-020-0150-x","volume":"5","author":"H Rui-Xue","year":"2020","unstructured":"Rui-Xue H, Ping-Kun Z. DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer. Signal Transd Target Ther. 2020;5:60.","journal-title":"Signal Transd Target Ther"},{"key":"3935_CR2","doi-asserted-by":"publisher","first-page":"8139","DOI":"10.2147\/IJN.S352169","volume":"16","author":"G Liuyun","year":"2021","unstructured":"Liuyun G, Yujie Z, Chengcheng L, Mingzhen Z, Suxia H. Application of Radiosensitizers in Cancer Radiotherapy. Int J Nanomed. 2021;16:8139\u20138139.","journal-title":"Int J Nanomed"},{"key":"3935_CR3","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1038\/s12276-021-00640-9","volume":"53","author":"S Tatsuya","year":"2021","unstructured":"Tatsuya S, Minoru K, Jin-Min N, Hiroshi H. Tumor microenvironment and radioresistance. Exp Mol Med. 2021;53:1029\u201335.","journal-title":"Exp Mol Med"},{"key":"3935_CR4","first-page":"188910","volume":"1878","author":"Y Xianzhe","year":"2023","unstructured":"Xianzhe Y, Lingling Z, Ting W, Lu L, Jiewei L, Guowei C, et al. Enhancing the anti-tumor response by combining DNA damage repair inhibitors in the treatment of solid tumors. Biochimica et Biophysica acta. 2023;1878:188910.","journal-title":"Biochimica et Biophysica acta"},{"key":"3935_CR5","first-page":"581","volume":"55","author":"G Somnath","year":"2021","unstructured":"Somnath G, Anu G. Activation of DNA damage response signaling in mammalian cells by ionizing radiation. Free Radic Res. 2021;55:581\u201394.","journal-title":"Free Radic Res"},{"key":"3935_CR6","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1089\/ars.2013.5668","volume":"21","author":"LS Wil","year":"2014","unstructured":"Wil LS, Fen X. Ionizing radiation-induced DNA damage, response, and repair. Antioxid Redox Signal. 2014;21:251\u20139.","journal-title":"Antioxid Redox Signal"},{"key":"3935_CR7","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1146\/annurev.biochem.052308.093131","volume":"79","author":"RL Michael","year":"2010","unstructured":"Michael RL. The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway. Annu Rev Biochem. 2010;79:181\u2013211.","journal-title":"Annu Rev Biochem"},{"key":"3935_CR8","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/cr.2008.1","volume":"18","author":"L Xuan","year":"2008","unstructured":"Xuan L, Wolf-Dietrich H. Homologous recombination in DNA repair and DNA damage tolerance. Cell Res. 2008;18:99\u2013113.","journal-title":"Cell Res"},{"key":"3935_CR9","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ctrv.2014.10.006","volume":"41","author":"W Ambber","year":"2015","unstructured":"Ambber W, Kum KK, Adrian PW. Targeting homologous recombination, new pre-clinical and clinical therapeutic combinations inhibiting RAD51. Cancer Treat Rev. 2015;41:35\u201345.","journal-title":"Cancer Treat Rev"},{"key":"3935_CR10","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0378-1119(01)00335-3","volume":"264","author":"D Hui","year":"2001","unstructured":"Hui D, Wei L, Cheng-Kang Z, Hui X, Gang F, Wei-Rong J, et al. Genomic sequence and expression analyses of human chromatin assembly factor 1 p150 gene. Gene. 2001;264:187\u201396.","journal-title":"Gene"},{"key":"3935_CR11","doi-asserted-by":"publisher","DOI":"10.1126\/science.add8673","volume":"381","author":"L Chao-Pei","year":"2023","unstructured":"Chao-Pei L, Zhenyu Y, Jun X, Jie H, Aoqun S, Dongbo D, et al. Structural insights into histone binding and nucleosome assembly by chromatin assembly factor-1. Science. 2023;381:eadd8673.","journal-title":"Science"},{"key":"3935_CR12","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/nature15749","volume":"528","author":"C Sihem","year":"2015","unstructured":"Sihem C, Ulrich E, Barbara H, Youngsook L, Jernej M, Maria N, et al. The histone chaperone CAF-1 safeguards somatic cell identity. Nature. 2015;528:218.","journal-title":"Nature"},{"key":"3935_CR13","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1093\/nar\/gkw1024","volume":"45","author":"Y Chunying","year":"2017","unstructured":"Chunying Y, Shiladitya S, Pavana M, Joy M, Shuai J, Brooke H, et al. Regulation of oxidized base damage repair by chromatin assembly factor 1 subunit A. Nucleic Acids Res. 2017;45:739\u201348.","journal-title":"Nucleic Acids Res"},{"key":"3935_CR14","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.molcel.2018.01.031","volume":"69","author":"H Ting-Hsiang","year":"2018","unstructured":"Ting-Hsiang H, Faith F, Chin-Chuan C, Zih-Jie S, Barry S, Jessica K. The Histone Chaperones ASF1 and CAF-1 Promote MMS22L-TONSL-Mediated Rad51 Loading onto ssDNA during Homologous Recombination in Human Cells. Mol Cell. 2018;69:879\u201392.","journal-title":"Mol Cell"},{"key":"3935_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33028-y","volume":"13","author":"T Tanay","year":"2022","unstructured":"Tanay T, Ashna D, Joshua S, Emily M, Claudia M, George-Lucian M. Lagging strand gap suppression connects BRCA-mediated fork protection to nucleosome assembly through PCNA-dependent CAF-1 recycling. Nat Commun. 2022;13:5323.","journal-title":"Nat Commun"},{"key":"3935_CR16","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.tibs.2017.12.003","volume":"43","author":"S Albert","year":"2018","unstructured":"Albert S, Zhiguo Z. Replication-Coupled Nucleosome Assembly in the Passage of Epigenetic Information and Cell Identity. Trends Biochem Sci. 2018;43:136\u201348.","journal-title":"Trends Biochem Sci"},{"key":"3935_CR17","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1038\/s41418-025-01472-0","volume":"32","author":"X Feng","year":"2025","unstructured":"Feng X, Qi X, Bin C, Ruru W, Jie Z, Xipeng Z, et al. ZNF451 collaborates with RNF8 to regulate RNF168 localization and amplify ubiquitination signaling to promote DNA damage repair and regulate radiosensitivity. Cell Death Differ. 2025;32:1303\u201316.","journal-title":"Cell Death Differ"},{"key":"3935_CR18","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1038\/s41388-025-03288-1","volume":"44","author":"Z Jie","year":"2025","unstructured":"Jie Z, Bin C, Feng X, Ruru W, Xipeng Z, Zhicheng Y, et al. Phospho-TRIM21 orchestrates RPA2 ubiquitination switch to promote homologous recombination and tumor radio\/chemo-resistance. Oncogene. 2025;44:1106\u201317.","journal-title":"Oncogene"},{"key":"3935_CR19","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1016\/j.molcel.2022.04.031","volume":"82","author":"Z Jiao","year":"2022","unstructured":"Jiao Z, Shanshan T, Qiushi G, Kaiwen B, Guohui Y, Xiaodan W, et al. A PARylation-phosphorylation cascade promotes TOPBP1 loading and RPA-RAD51 exchange in homologous recombination. Mol Cell. 2022;82:2571\u20132587.e9.","journal-title":"Mol Cell"},{"key":"3935_CR20","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.1038\/s41418-022-01036-6","volume":"29","author":"Z Yan","year":"2022","unstructured":"Yan Z, Xinping H, Dan Z, Min W, Jiechen L, Shuyu Y, et al. Deubiquitinase OTUD6A promotes breast cancer progression by increasing TopBP1 stability and rendering tumor cells resistant to DNA-damaging therapy. Cell Death Differ. 2022;29:2531\u201344.","journal-title":"Cell Death Differ"},{"key":"3935_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05302-w","volume":"13","author":"W Ruru","year":"2022","unstructured":"Ruru W, Yajing S, Bin C, Feng X, Jie Z, Zhaoyang Z, et al. Protein disulfide isomerase blocks the interaction of LC3II-PHB2 and promotes mTOR signaling to regulate autophagy and radio\/chemo-sensitivity. Cell Death Dis. 2022;13:851.","journal-title":"Cell Death Dis"},{"key":"3935_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2026.218513","volume":"650","author":"Y Zhicheng","year":"2026","unstructured":"Zhicheng Y, Ruru W, Bin C, Xipeng Z, Jie Z, Shenglan Z, et al. RNF185 orchestrates replication fork restart and homologous recombination through temporal RPA1 ubiquitination switching. Cancer Lett. 2026;650:218513. 10.","journal-title":"Cancer Lett"},{"key":"3935_CR23","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.cels.2020.12.001","volume":"12","author":"EL Joshua","year":"2021","unstructured":"Joshua EL, Tom EF, David AB, Cristina MF, Melissa LK. Personalized Genome-Scale Metabolic Models Identify Targets of Redox Metabolism in Radiation-Resistant Tumors. Cell Syst. 2021;12:68\u201381.e11.","journal-title":"Cell Syst"},{"key":"3935_CR24","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1038\/nsmb.1470","volume":"15","author":"Q Jean-Pierre","year":"2008","unstructured":"Jean-Pierre Q, Annabelle G, Adam JLC, Dani\u00e8le R, Genevi\u00e8ve A. The HP1-p150\/CAF-1 interaction is required for pericentric heterochromatin replication and S-phase progression in mouse cells. Nat Struct Mol Biol. 2008;15:972\u20139.","journal-title":"Nat Struct Mol Biol"},{"key":"3935_CR25","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1534\/genetics.118.301858","volume":"211","author":"JY Tiffany","year":"2019","unstructured":"Tiffany JY, Yi C, Joseph I, Ann LK. Modulation of Gene Silencing by Cdc7p via H4 K16 Acetylation and Phosphorylation of Chromatin Assembly Factor CAF-1 in Saccharomyces cerevisiae. Genetics. 2019;211:1219\u201337.","journal-title":"Genetics"},{"key":"3935_CR26","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/s41586-024-07620-9","volume":"631","author":"C Hengxing","year":"2024","unstructured":"Hengxing C, Yun L, Huafu L, Xiancong C, Huafeng F, Deli M, et al. NBS1 lactylation is required for efficient DNA repair and chemotherapy resistance. Nature. 2024;631:663\u20139.","journal-title":"Nature"},{"key":"3935_CR27","doi-asserted-by":"publisher","first-page":"5327","DOI":"10.1158\/0008-5472.CAN-17-1355","volume":"77","author":"S Elizabeth","year":"2017","unstructured":"Elizabeth S, Kayla MC, Cheryl JS, Mary JM, Maria D, Jeffrey B, et al. MRE11 Promotes Tumorigenesis by Facilitating Resistance to Oncogene-Induced Replication Stress. Cancer Res. 2017;77:5327\u201338.","journal-title":"Cancer Res"},{"key":"3935_CR28","first-page":"4681","volume":"14","author":"L Tanzhen","year":"2017","unstructured":"Tanzhen L, Jingjing W, Chao J, Chen W, Xiaoqin Z, Yan D, et al. CHAF1A, the largest subunit of the chromatin assembly factor 1 complex, regulates the growth of H1299 human non-small cell lung cancer cells by inducing G0\/G1 cell cycle arrest. Exp Ther Med. 2017;14:4681\u20136.","journal-title":"Exp Ther Med"},{"key":"3935_CR29","first-page":"1","volume":"182","author":"O Michele","year":"2020","unstructured":"Michele O, Tiffany C, Alejandro \u00c1, Kejiao L, Matthew JS, Michal Z, et al. A Genetic Map of the Response to DNA Damage in Human Cells. Cell. 2020;182:1\u201316.","journal-title":"Cell"},{"key":"3935_CR30","doi-asserted-by":"publisher","first-page":"11099","DOI":"10.3390\/ijms231911099","volume":"23","author":"G Amogh","year":"2022","unstructured":"Amogh G, Nick R, Sara L, Caleb H, Michael JO, Normand C, et al. Unorthodox PCNA Binding by Chromatin Assembly Factor 1. Int J Mol Sci. 2022;23:11099.","journal-title":"Int J Mol Sci"},{"key":"3935_CR31","first-page":"1","volume":"188","author":"T Jakob","year":"2025","unstructured":"Jakob T, Simon T, Shuyao S, Franziska G, Sandra G, Susanne IW, et al. The human proteome with direct physical access to DNA. Cell. 2025;188:1\u201317.","journal-title":"Cell"},{"key":"3935_CR32","volume":"6","author":"W Bing","year":"2025","unstructured":"Bing W, Hai-Xiang Z, Jing-Hua H, Qian T, Dan-Xia D, Zhi-Da Z, et al. Chromatin assembly factor 1 subunit A promotes TLS pathway by recruiting E3 ubiquitin ligase RAD18 in cancer cells. Cell Death Dis. 2025;6:147.","journal-title":"Cell Death Dis"},{"key":"3935_CR33","doi-asserted-by":"publisher","first-page":"5083","DOI":"10.1093\/nar\/gkw106","volume":"44","author":"Z Kuo","year":"2016","unstructured":"Kuo Z, Yuan G, Jingjing L, Rebecca B, Junhong H, Huanhuan L, et al. A DNA binding winged helix domain in CAF-1 functions with PCNA to stabilize CAF-1 at replication forks. Nucleic Acids Res. 2016;44:5083\u201394.","journal-title":"Nucleic Acids Res"},{"key":"3935_CR34","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.3390\/biomedicines11041184","volume":"11","author":"W Bing","year":"2023","unstructured":"Bing W, Dan-Xia D, Lian-Di L, Zhi-Da Z, Ya-Qi Z, Ke D, et al. Co-Expression of Chromatin Assembly Factor 1 Subunit A and Proliferating Cell Nuclear Antigen Is a Prognostic Biomarker of Esophageal Cancer. Biomedicines. 2023;11:1184.","journal-title":"Biomedicines"},{"key":"3935_CR35","doi-asserted-by":"crossref","unstructured":"Ou D, Thales N, Bin F, Eric AW, Rachael HM, Erin MG, et al. MSH6 modulates PARP inhibitor sensitivity in BRCA-proficient high-grade serous ovarian cancer. Cancer Res. 8S1:1872. 2025.","DOI":"10.1158\/1538-7445.AM2025-1872"},{"key":"3935_CR36","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/HEP.0000000000000709","volume":"80","author":"C For-Fan","year":"2024","unstructured":"For-Fan C, Vincent Wai-Hin Y, Jialing S, Don Wai-Ching C, Cheuk-Ting L, Bowie Po-Yee W, et al. Inhibition of CAF-1 histone chaperone complex triggers cytosolic DNA and dsRNA sensing pathways and induces intrinsic immunity of hepatocellular carcinoma. Hepatology. 2024;80:295\u2013311.","journal-title":"Hepatology"},{"key":"3935_CR37","doi-asserted-by":"publisher","first-page":"1108004","DOI":"10.3389\/fgene.2023.1108004","volume":"14","author":"S Xia","year":"2023","unstructured":"Xia S, Qiushuang M, Yahong C, Huangwei H, Jing Q, Mengchen Z, et al. Overexpression of CHAF1A is associated with poor prognosis, tumor immunosuppressive microenvironment and treatment resistance. Front Genet. 2023;14:1108004.","journal-title":"Front Genet"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03935-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03935-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03935-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T22:02:12Z","timestamp":1789509732000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03935-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,4]]},"references-count":37,"journal-issue":{"issue":"38","published-print":{"date-parts":[[2026,10,7]]}},"alternative-id":["3935"],"URL":"https:\/\/doi.org\/10.1038\/s41388-026-03935-1","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,4]]},"assertion":[{"value":"24 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests. We declare that the content of this manuscript is original and has not been published or accepted for publication, in whole or in part, in any form (other than as an abstract or other preliminary publication). We also confirm that no part of this manuscript is currently under consideration for publication elsewhere.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The research protocol was approved by an Institutional Review Board. All human participants provided signed informed consent, and the study was conducted in accordance with the ethical standards of the institutional research committee and with the Helsinki Declaration. Formal approval was granted by the Ethics Committee of Hefei Institutes of Physical Science, Chinese Academy of Sciences (ethics approval no. YXLL-2025-04). All animal studies were conducted in compliance with institutional guidelines and were approved by the Animal Care and Use Committee of Hefei Institutes of Physical Science, Chinese Academy of Sciences (ethics approval no. DWLL(E)-2025-12).","order":2,"name":"Ethics","label":"Ethics Statement","group":{"name":"EthicsHeading","label":"Ethics"}}]}}